Remote | Biotech Investment Analyst — $125–$185​/hour

Consulting Opportunity in Biotech Investment

We are sharing a specialised part-time consulting opportunity for experienced biotech investment professionals with deep expertise in evaluating pharmaceutical assets, clinical-stage drug-development programmes, company fundamentals, and investment opportunities within the US biotech and healthcare market.

This role supports an expert evaluation initiative focused on commercial drugs and drug-development programmes. Selected professionals will develop and critique structured evaluation rubrics, assess individual drug assets and the companies behind them, and apply specialist investment judgement across a focused set of biotech companies.

Drug Asset Assessment

• Evaluate commercial and clinical-stage drug assets across different therapeutic areas
• Assess mechanism of action, biological rationale, clinical data, development progress, and regulatory considerations
• Analyse competitive positioning within relevant therapeutic and treatment landscapes
• Identify key scientific, clinical, regulatory, and commercial value drivers
• Flag unsupported assumptions, evidence gaps, or material risks within asset assessments

Company & Investment Analysis

• Conduct end-to-end assessments of biotech and pharmaceutical companies
• Evaluate pipeline quality, company strategy, competitive differentiation, and major catalysts
• Assess the relationship between individual drug assets and overall company valuation
• Review investment-style theses for analytical strength, supporting evidence, and internal consistency
• Identify weak, overly confident, or missing assumptions within investment conclusions
• Apply consistent investment judgement across approximately 5–10 companies during the pilot

Clinical & Commercial Evaluation

• Interpret clinical trial results and assess the strength and relevance of available evidence
• Evaluate potential differentiation against existing and emerging standards of care
• Analyse addressable markets, competitive dynamics, development timelines, and commercial opportunity
• Assess how clinical, regulatory, and market developments may affect asset and company value
• Distinguish between well-supported conclusions and speculative investment assumptions

Rubric Development & Expert Review

• Create structured evaluation rubrics for biotech companies and drug-development programmes
• Critique existing rubrics for completeness, realism, and investment relevance
• Define criteria reflecting experienced biotech investment judgement
• Identify missing considerations or weak assumptions in analytical frameworks
• Provide clear written reasoning supporting evaluation decisions

Ideal Profile

• 5+ years of experience evaluating biotech, pharmaceutical, or healthcare companies or assets
• Professional experience as a biotech or healthcare investment analyst, ideally within a specialist investment fund
• Strong familiarity with biotech and pharmaceutical drug-development programmes
• Experience assessing drug assets from scientific, clinical, commercial, and investment perspectives
• Strong understanding of clinical data, mechanisms of action, competitive landscapes, and biotech valuation drivers
• Ability to evaluate both individual assets and the broader companies developing them
• Experience developing, reviewing, or presenting investment theses
• Strong analytical judgement and ability to identify unsupported or incomplete assumptions
• US-based or possessing deep professional experience covering the US biotech and healthcare investment market
• Availability for approximately 10–20 hours over an initial 1–2 week pilot

Engagement Details

• Part-time independent contractor engagement
• Approximately 10–20 hours over an initial 1–2 week pilot
• Fully remote with flexible scheduling
• Compensation of $125–$185/hour
• Potential for recurring project work for strong contributors
• Work must be completed without using confidential or proprietary information belonging to any employer, client, fund, institution, or other third party
• H1-B and STEM OPT support is unavailable for this engagement

About the Platform

This opportunity is available through 24-MAG LLC. We connect experienced professionals with remote consulting opportunities across technical, evaluation, and project-based work streams.

By submitting this application, you acknowledge that your information may be processed by 24-MAG LLC for recruitment and opportunity matching in accordance with our Privacy Policy.